Xencor, Inc. (NASDAQ:XNCR) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, thank you for standing by. And welcome to the Xencor's Fourth Quarter and Year End 2022 Conference Call. At this time, all participants are in a listen-only mode.
Xencor Inc (XNCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 5,282,516 | $137,556,717 | 4.18% | |
| 2. | Rhenman & Partners Asset Management Henrik Rhenman | 294,076 | $7,657,739 | 0.79% | |
| 3. | Hudson Bay Capital Management Sander Gerber | 177,500 | $4,622,100 | +23% | 0.04% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 173,900 | $4,528,356 | +63% | 0.01% |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 123,127 | $3,206,227 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.87 | 12,641 | Large Shareholder | 5,090,000 | 2019-06-06 | Filing | |
| $29.87 | 14,611 | Large Shareholder | 5,077,359 | 2019-05-02 | Filing | |
| $29.77 | 3,500 | Large Shareholder | 5,062,748 | 2019-03-25 | Filing | |
| $29.96 | 2,000 | Large Shareholder | 5,059,248 | 2019-03-22 | Filing | |
| $29.90 | 1,100 | Large Shareholder | 5,057,248 | 2019-03-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.88 | 1,094 | Officer | 73,364 | 2023-03-09 | Filing | |
| $29.88 | 711 | Officer | 36,976 | 2023-03-09 | Filing | |
| $29.88 | 711 | Officer | 126,230 | 2023-03-09 | Filing | |
| $29.88 | 1,230 | Officer | 147,726 | 2023-03-09 | Filing | |
| $29.88 | 2,602 | Officer, Director | 249,701 | 2023-03-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 10,648,167 | $277,278,269 | 0% | |
| 2. | 6,652,233 | $173,224,148 | 0% | |
| 3. | 6,216,903 | $161,888,154 | 0.14% | |
| 4. | 3,825,353 | $99,612,197 | 0% | |
| 5. | 3,156,051 | $82,183,568 | 0% |
News See All
12 Best Small-Cap Healthcare Stocks To Buy Now
Macroeconomic headwinds and recessionary concerns will not weaken healthcare deals next year after the market experienced resilient mergers and acquisitions in 2022.
Were Hedge Funds Right About Xencor Inc (XNCR)?
In this article we will take a look at whether hedge funds think Xencor Inc (NASDAQ:XNCR) is a good investment right now.
Is XNCR A Good Stock To Buy Now?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Xencor Inc (XNCR): Hedge Funds Are Snapping Up
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Were Hedge Funds Right About Selling Xencor Inc (XNCR)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Here is What Hedge Funds Think About Xencor Inc (XNCR)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Hedge Funds Are Selling Xencor Inc (XNCR)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Billionaire Hedge Funds
